Brief: Bluebird Bio Announces Receipt Of Expected Notice From Nasdaq
26/04/2024 21:10
April 26 (Reuters) - bluebird bio Inc BLUE.O :
* BLUEBIRD BIO ANNOUNCES RECEIPT OF EXPECTED NOTICE FROM
NASDAQ
Source text for Eikon: ID:nBw37TNy0a
Further company coverage: BLUE.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on bluebird bio
See all newsBrief: Bluebird Bio Announces Completion Of Acquisition By Carlyle And SK Capital
Brief: Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
Brief: Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment